Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Head and Neck Cancer

Free Subscription 05.01.2026 1 Am J Gastroenterol 6 Anticancer Res 3 BMC Cancer 1 BMC Surg 1 Clin Cancer Res 1 Dis Esophagus 1 Gastrointest Endosc 4 Head Neck 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Nucl Med 22 Oral Oncol 1 Otolaryngol Head Neck Surg 1 PLoS One 2 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. SAWAS T, Jones AR, Alsawas R, Talluri R, et al
   Overall and Cause-Specific Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Population-Based Studies.
   Am J Gastroenterol. 2026;121:140-150.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. WU PW, Lee HP, Lin YH
   Curative Surgery Following Induction Chemotherapy for Sinonasal Small Cell Neuroendocrine Carcinoma With Contraindication to Radiotherapy.
   Anticancer Res. 2026;46:539-546.
   PubMed         Abstract available
   
   
3. NISHIKAWA T, Higaki A, Mitani S, Higashi H, et al
   Association Between Human Papillomavirus Infection Status and Coronary Artery Calcification in Patients With Oropharyngeal Cancer.
   Anticancer Res. 2026;46:487-491.
   PubMed         Abstract available
   
   
4. HUANG YC, Wang CC, Yang C, Li Y, et al
   Protopanaxadiol Induces Apoptosis in NPC/HK1 Human Nasopharyngeal Carcinoma Cells via the Fas/Caspase-8 Signaling Pathway.
   Anticancer Res. 2026;46:195-204.
   PubMed         Abstract available
   
   
5. SEKINO N, Murakami K, Toyozumi T, Uesato M, et al
   Clinical Predictors of Neoadjuvant Chemotherapy Efficacy in Esophageal Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:309-318.
   PubMed         Abstract available
   
   
6. NAKAMURA S, Kitazawa M, Yamamoto Y, Miyazaki S, et al
   High Incidence of Asymptomatic Pulmonary Embolism Detected on Early Postoperative CT After Thoracoscopic Esophagectomy for Esophageal Cancer: A Prospective Observational Study.
   Anticancer Res. 2026;46:371-383.
   PubMed         Abstract available
   
   
7. DAIS P, Papageorgiou K, Mastronikolis N, Papageorgiou GF, et al
   Real-time Capacity Reactance-based Innovative Technology for Detecting Malignant Cells: An Experimental Implementation in Head and Neck Tumors.
   Anticancer Res. 2026;46:237-247.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. BABA AM, Shyanti RK, Hajam MA, Nissa N, et al
   Role of histone acetylation in the regulation of CD36 and ANGPTL1 in esophageal squamous cell carcinoma.
   BMC Cancer. 2025 Dec 23. doi: 10.1186/s12885-025-15350.
   PubMed        
   
   
9. FELLER G, Mmereki D, Mahomed F, Khammissa RA, et al
   Demographic, clinicopathological, and treatment of oral squamous cell carcinoma patients at a Johannesburg Academic Hospital, South Africa: a 5-year retrospective observational study.
   BMC Cancer. 2025;25:1917.
   PubMed         Abstract available
   
   
10. BAKHSHANDEH M, Mohammadi P, Parvaz N, Lotfi M, et al
    Study of FOXO1/pFOXO1, lncRNA ADAMTS9-AS2, and miR-96-5p in laryngeal squamous cell carcinoma.
    BMC Cancer. 2025;25:1882.
    PubMed         Abstract available
    
    

    
    BMC Surg

11. LIN R, Lin Y, Su W, Weng G, et al
    Uniportal thoracoscopic and single-incision plus one port laparoscopic esophagectomy with direct vision retrosternal reconstruction for esophageal cancer a single center retrospective cohort study.
    BMC Surg. 2025;25:609.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

12. RISCHIN D, Hansen AR, Cohen EEW, Tahara M, et al
    INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Clin Cancer Res. 2025 Dec 22. doi: 10.1158/1078-0432.CCR-25-1197.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

13. ANDREWS WG, Blitz S, Sewell M, Molena D, et al
    The location and degree of residual disease determines recurrence patterns and survival in patients with esophageal adenocarcinoma after trimodal therapy.
    Dis Esophagus. 2025;38:doaf125.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

14. LIU C, Lv H, Li P
    Navigating the gray zone: refining risk stratification after endoscopic resection for cervical esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2025 Dec 23:S0016-5107(25)02137.
    PubMed        
    
    

    
    Head Neck

15. JANSEN RW, Martens RM, Abdulrahman O, Peferoen L, et al
    Efficacy of Multimodal Work-Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary.
    Head Neck. 2025 Dec 26. doi: 10.1002/hed.70147.
    PubMed         Abstract available
    
    
16. VUPPALA R, Long S, Sharbel D, Weir F, et al
    Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis.
    Head Neck. 2025 Dec 26. doi: 10.1002/hed.70140.
    PubMed         Abstract available
    
    
17. LI H, Ding Y, Wu Y, Fang Y, et al
    Greater Attention to Gingival Cancer and Floor of Mouth Cancer: Based on a Retrospective Analysis of Oral Cancer Across Different Subsites.
    Head Neck. 2025 Dec 22. doi: 10.1002/hed.70145.
    PubMed         Abstract available
    
    
18. MASSONET H, Goeleven A, Nuyts S, Vergauwen A, et al
    Feasibility and Adherence to Home-Based Intensive Treatment Programs for Chronic Radiation-Associated Dysphagia in Head and Neck Cancer Survivors-The HIT-CRAD Trial.
    Head Neck. 2025 Dec 20. doi: 10.1002/hed.70136.
    PubMed         Abstract available
    
    

    
    Int J Cancer

19. HADJI M, Rashidian H, Marzban M, Rezaianzadeh A, et al
    The association between waterpipe smoking and head and neck squamous cell carcinoma: A multicenter case-control study in Iran.
    Int J Cancer. 2025 Dec 26. doi: 10.1002/ijc.70258.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

20. HUISKES M, Astreinidou E, de Jong M, den Haan N, et al
    Qualitative Blinded Clinical Assessment of Automated and Manual IMPT Plans for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Dec 19:S0360-3016(25)06503.
    PubMed         Abstract available
    
    

    
    J Nucl Med

21. LAZZERONI M, Ureba A, Schafer H, Nicolay NH, et al
    Biologically Individualized Radiotherapy Based on PET: A Novel Approach to Treatment Optimization of Head and Neck Cancer.
    J Nucl Med. 2025 Dec 30:jnumed.125.270403. doi: 10.2967/jnumed.125.270403.
    PubMed         Abstract available
    
    

    
    Oral Oncol

22. LIU Q, Wei JN, Zhou JY, Zhang CR, et al
    Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma.
    Oral Oncol. 2025;173:107825.
    PubMed         Abstract available
    
    
23. THIAGARAJAN S, Rukmangathan T, Sharma D, Kakade A, et al
    Prevalence, risk Factors, and quality of life in patients with head and neck lymphedema following treatment for head and neck Cancer: The HeNLy-1 study.
    Oral Oncol. 2025;173:107838.
    PubMed         Abstract available
    
    
24. PARK SE, Hong SH, Park JO, Kim SY, et al
    Head and neck squamous cell carcinoma following allogeneic bone marrow transplantation: Clinical features, genomic Alterations, and limited efficacy of palliative chemotherapy.
    Oral Oncol. 2025;173:107827.
    PubMed         Abstract available
    
    
25. ZHANG M, Song J, Yuan Y, Cao X, et al
    Ensemble learning-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
    Oral Oncol. 2025;173:107841.
    PubMed         Abstract available
    
    
26. CHAUDHRY M, Elfar A, Rowsey K, Neel A, et al
    Safety reporting in head and neck squamous cell carcinoma clinical Trials: A comparative analysis of ClinicalTrials.gov data and published research.
    Oral Oncol. 2025;173:107840.
    PubMed         Abstract available
    
    
27. LECHIEN JR, Paleri V, Baudouin R, Brunet A, et al
    European surgical guidelines: transoral robotic surgery for head and neck cancers.
    Oral Oncol. 2025;173:107826.
    PubMed         Abstract available
    
    
28. JAKOBSEN KK, H Rasmussen J, Melchiors J, Agander TK, et al
    Head and neck cancer trends in Denmark: A nationwide, 40-Year data analysis.
    Oral Oncol. 2025;173:107843.
    PubMed         Abstract available
    
    
29. XIAO G, Ning L, Chen L, Zhang S, et al
    Exercise and quality of life in head and neck squamous cell carcinoma patients receiving neoadjuvant immuno-chemotherapy: A randomized, open-labeled phase II trial.
    Oral Oncol. 2025;173:107844.
    PubMed         Abstract available
    
    
30. NIU S, Ding J, Chen H, Zhu Z, et al
    Positron emission tomography-based intratumoral spatial diversity for prognosis in nasopharyngeal carcinoma.
    Oral Oncol. 2026;173:107845.
    PubMed         Abstract available
    
    
31. FENG Y, Al-Aroomi MA, Chen J, Song S, et al
    Influencing factors on occurrence and prognosis of oral squamous cell carcinoma after organ transplantation.
    Oral Oncol. 2026;172:107824.
    PubMed         Abstract available
    
    
32. BAJAJ K, Ramadoss R, Sundar S, Selvam SP, et al
    Patterns of metastasis and nodal disease in tongue and buccal carcinomas: Case-based reflections in Delhi NCR Region.
    Oral Oncol. 2026;172:107816.
    PubMed         Abstract available
    
    
33. CHIARI F, Carobbio ALC, Ferrari M, Nicolai P, et al
    Survival rates and oncologic outcomes of adeno squamous carcinoma of oral cavity: A systematic review.
    Oral Oncol. 2026;172:107821.
    PubMed         Abstract available
    
    
34. AYOO K, Koo E, Villemure-Poliquin N, Fu R, et al
    Cerebrovascular events after head and neck radiation therapy: A systematic review and Meta-Analysis.
    Oral Oncol. 2026;172:107810.
    PubMed         Abstract available
    
    
35. HAFSTROM A, Hammerlid E, Beran M, Olin M, et al
    Treatment and outcome for 2,111 patients with vermilion lip squamous cell carcinoma: A nationwide, population-based study from the SweHNCR.
    Oral Oncol. 2026;172:107818.
    PubMed         Abstract available
    
    
36. HOLDORF F, Schliephake H, Goldstein K, Gruber LJ, et al
    A pilot study of a digital workflow for navigated tumor bed marking to reduce clinical target volume during adjuvant radiotherapy for oral squamous cell carcinoma.
    Oral Oncol. 2026;172:107820.
    PubMed         Abstract available
    
    
37. HU D, Dai Z, Feng Y, Su X, et al
    Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?
    Oral Oncol. 2026;172:107817.
    PubMed         Abstract available
    
    
38. PADOVAN BV, Beenker M, Langendijk JA, van der Laan HP, et al
    Integrated geriatric assessment and intervention in the head and neck oncology care pathway reduces adverse events and does not affect survival.
    Oral Oncol. 2026;172:107811.
    PubMed         Abstract available
    
    
39. WU WJ, An PG, Zhang ZQ, Shen LH, et al
    Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trial.
    Oral Oncol. 2026;172:107809.
    PubMed         Abstract available
    
    
40. HACK S, Attal R, Geva K, Farzad A, et al
    Blinded comparative evaluation of GPT-generated, online search-derived, and guideline-based answers for HPV-associated oropharyngeal cancer.
    Oral Oncol. 2025;172:107813.
    PubMed         Abstract available
    
    
41. NYIRJESY SC, Al-Inaya Y, Zhang S, Karadaghy OA, et al
    Incidence of HPV-independent second primary malignancies following treatment of HPV-associated malignancy.
    Oral Oncol. 2025;172:107790.
    PubMed         Abstract available
    
    
42. ZHAO M, Liu Z, Kawabe M, Osman AA, et al
    Establishment and characterization of a new immortalized human oral keratinocyte (HOK) cell line harboring various TP53 mutations.
    Oral Oncol. 2026;172:107799.
    PubMed         Abstract available
    
    
43. LI Y, Kou Q, Zheng C, Nov P, et al
    Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC.
    Oral Oncol. 2025;172:107789.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

44. ARCH R, Ma SJ, Gogineni E, Baliga S, et al
    Delays in Radiation Therapy for Head and Neck Cancer: The Role of Pre-Radiation Dental Clearance.
    Otolaryngol Head Neck Surg. 2025 Dec 26. doi: 10.1002/ohn.70096.
    PubMed         Abstract available
    
    

    
    PLoS One

45. KANG BC, Yi SE, Kang WS, Ahn JH, et al
    Treatment outcomes and prognostic factors in external auditory canal squamous cell carcinoma.
    PLoS One. 2025;20:e0339860.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

46. YOU J, Ou H, Zhang Y, Wu X, et al
    NPC-SurvAI: A fully automated deep learning framework for prognostic prediction and risk stratification in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2026;214:111223.
    PubMed         Abstract available
    
    
47. UGWU GC, Jalali F, Liu G, Li G, et al
    The actual performance of ML/AI models in predicting radiation-induced toxicity in head and neck cancer: a systematic review and meta-analysis.
    Radiother Oncol. 2025;216:111350.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.